Helicobacter pylori (H. pylori) is a recalcitrant pathogen, which can cause gastric disorders.
During the past decades, polypharmacy‐based regimens, such as triple and quadruple …

Given the high global prevalence and mortality associated with gastric cancer, and its known
causal link with Helicobacter pylori infection, it is important to have a biomarker to identify …

This study aimed to investigate whether the gastroprotective effects of three types of
bacterial levans are correlated with their prebiotic-associated anti-inflammatory/antioxidant …

Helicobacter Pylori (H. Pylori) cause peptic ulcer disease (PUD), but the inflammasome's
role in PUD is not well understood. Therefore this study has investigated inflammasome …

摘要目的: 探讨荆花胃康胶丸联合标准四联疗法对幽门螺杆菌(Hp) 相关十二指肠溃疡(DU)
患者血清肽类胃肠激素, 胃蛋白酶原和炎症介质的影响. 方法: 选择2019 年3 月~ 2021 年11 …

Background Research evidences suggest that diverse forms of programmed cell death
(PCD) are involved in the helicobacter pylori (H. pylori)-induced gastric inflammation and …

This study aimed to investigate the treatment effects of Bifidobacterium quadruple viable
tablets combined with quadruple therapy on Helicobacter pylori (Hp)-infected peptic ulcer in …

Background: The worldwide prevalence of Helicobacter pylori is about 50%. This bacterium
needs a number of virulence factors for pathogenesis. Objectives: This study aimed to …

摘要目的: 探讨舌三针联合舌下刺络放血治疗脑卒中后吞咽障碍的临床效果. 方法:
采取前瞻性随机对照的研究方法, 将2018 年1 月至2021 年1 月60 例脑卒中后吞咽障碍患者分 …

The immuno-regulatory cytokine interleukin 10 (IL-10) is important in reducing the
inflammatory response during H. pylori infection. The goal of our study was to explain how …